This evidence imply that lncRNAs can reduce the activation response of HSC by inhibiting the activation of PI3K/AKT/mTOR signaling pathway in liver fibrosis (Karin et al., 2002; De Simone et al., 2015). The gene discussed is AKT1; the disease is Hepatic fibrosis.